BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32571808)

  • 1. Impact of the COVID-19 outbreak on cancer patient flow and management: experience from a large university hospital in Spain.
    Manso L; De Velasco G; Paz-Ares L
    ESMO Open; 2020 Jun; 4(Suppl 2):e000828. PubMed ID: 32571808
    [No Abstract]   [Full Text] [Related]  

  • 2. Challenges Faced by Medical Journals During the COVID-19 Pandemic.
    Cannistra SA; Haffty BG; Ballman K
    J Clin Oncol; 2020 Jul; 38(19):2206-2207. PubMed ID: 32267782
    [No Abstract]   [Full Text] [Related]  

  • 3. Telehealth in Oncology During the COVID-19 Outbreak: Bringing the House Call Back Virtually.
    Liu R; Sundaresan T; Reed ME; Trosman JR; Weldon CB; Kolevska T
    JCO Oncol Pract; 2020 Jun; 16(6):289-293. PubMed ID: 32364826
    [No Abstract]   [Full Text] [Related]  

  • 4. Rethinking Clinical Trials Reform During the COVID-19 Pandemic.
    Nabhan C; Choueiri TK; Mato AR
    JAMA Oncol; 2020 Sep; 6(9):1327-1329. PubMed ID: 32761101
    [No Abstract]   [Full Text] [Related]  

  • 5. Oncology Care Delivery in the COVID-19 Pandemic: An Opportunity to Study Innovations and Outcomes.
    Cinar P; Cox J; Kamal A; Bickel K; Krzyzanowska M; Armitage J; Ganti AK; Ward J; Wong S; Lonial S; Bosserman L
    JCO Oncol Pract; 2020 Aug; 16(8):431-434. PubMed ID: 32463764
    [No Abstract]   [Full Text] [Related]  

  • 6. COVID-19 and cancer: do we really know what we think we know?
    Robinson AG; Gyawali B; Evans G
    Nat Rev Clin Oncol; 2020 Jul; 17(7):386-388. PubMed ID: 32424196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [What I talk about when I talk about COVID-19].
    Aspelund T
    Laeknabladid; 2020 Sep; 106(9):395. PubMed ID: 32902397
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer patients in COVID-19 outbreak: something more than Suram fortress.
    Ferrari D; Violati M; Codecà C
    Med Oncol; 2020 May; 37(7):57. PubMed ID: 32468517
    [No Abstract]   [Full Text] [Related]  

  • 9. In Defense of Our Patients: Indirect Negative Neurological Consequences of SARS-CoV-2 in the New York Epicenter.
    Cooper JB; Amin AG; Kim MG; Stein AA; Dominguez J; Amuluru K; Tyagi R; Mayer S; Gandhi CD; Al-Mufti F
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105127. PubMed ID: 32912525
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of COVID-19 Pandemic on Mechanical Thrombectomy for Acute Ischemic Stroke Treatment in United States.
    Qureshi AI; Siddiq F; French BR; Gomez CR; Jani V; Hassan AE; Suri MFK
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105140. PubMed ID: 32912573
    [No Abstract]   [Full Text] [Related]  

  • 11. Aerosol Treatments During COVID-19 Pandemic: A Personal Journey.
    Amirav I
    J Aerosol Med Pulm Drug Deliv; 2020 Oct; 33(5):288-289. PubMed ID: 32723207
    [No Abstract]   [Full Text] [Related]  

  • 12. Response of Cardiac Surgery Units to COVID-19: An Internationally-Based Quantitative Survey.
    Gaudino M; Chikwe J; Hameed I; Robinson NB; Fremes SE; Ruel M
    Circulation; 2020 Jul; 142(3):300-302. PubMed ID: 32392425
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 seroprevalence in oncology healthcare professionals and patients with cancer at a tertiary care centre during the COVID-19 pandemic.
    Fuereder T; Berghoff AS; Heller G; Haslacher H; Perkmann T; Strassl R; Berger JM; Puhr HC; Kreminger J; Moik F; Schubert L; Starzer AM; Steindl A; Winkler S; Preusser M; Tobudic S
    ESMO Open; 2020 Sep; 5(5):e000889. PubMed ID: 32878898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient Risk.
    Lou E; Beg S; Bergsland E; Eng C; Khorana A; Kopetz S; Lubner S; Saltz L; Shankaran V; Zafar SY
    JCO Oncol Pract; 2020 Jul; 16(7):383-388. PubMed ID: 32352884
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescreening for COVID-19 in patients receiving cancer treatment using a patient-reported outcome platform.
    Peeters M; van Dam P; Rasschaert MA; Vulsteke C; De Keersmaecker S; Croes L; Van Brussel I; Ravelingien J; Janssens A; Prenen H
    ESMO Open; 2020 Jun; 5(3):e000817. PubMed ID: 32571785
    [No Abstract]   [Full Text] [Related]  

  • 16. Cancer and Coronavirus Disease 2019 (COVID-19)-Facing the "C Words".
    Shah UA
    JAMA Oncol; 2020 Sep; 6(9):1330-1331. PubMed ID: 32379856
    [No Abstract]   [Full Text] [Related]  

  • 17. Chilblains and COVID19 infection: Causality or coincidence? How to proceed?
    Pistorius MA; Blaise S; Le Hello C; ; Barbarot S; Dréno B
    J Med Vasc; 2020 Jul; 45(4):221-223. PubMed ID: 32571563
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictors of Refractory Coronavirus Disease (COVID-19) Pneumonia.
    Abu-Raya B
    Clin Infect Dis; 2020 Jul; 71(15):895-896. PubMed ID: 32271373
    [No Abstract]   [Full Text] [Related]  

  • 19. The need of COVID19 free hospitals to maintain cancer care.
    Restivo A; De Luca R; Spolverato G; Delrio P; Lorenzon L; D'Ugo D; Gronchi A;
    Eur J Surg Oncol; 2020 Jun; 46(6):1186-1187. PubMed ID: 32336627
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of a Patient-Centered Framework for Oncology Clinicians to Address Uncertainty in Cancer Care During the COVID-19 Pandemic.
    Dhawan N; Prommer E; Sinclair CT; Subbiah IM
    Curr Treat Options Oncol; 2020 Oct; 21(12):99. PubMed ID: 33119833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.